Our People

CREATE Affiliates

	Ms Chloe Lawler Chloe Lawler is an early career researcher having graduated with Honours from the University of New South Wales in the School of Biotechnology and Biomolecular Sciences in December of 2022. She is a Research Assistant working on multiple studies and publications as part of the Faculty of Medicine and Health Sciences at the University of Sydney and Royal Prince Alfred Hospital under the supervision of Professor Tamera Corte. Chloe is embedded in activities on behalf of the Centre of Research Excellence in Pulmonary Fibrosis as well as the Australian Interstitial Lung Disease Registry. In her short career she has collaborations with the Blizard Institute in the Faculty of Medicine and Dentistry, Queen Mary University of London, Monash University and University of Queensland. Her research interests include Interstitial Lung Diseases, with particular interest in Idiopathic Pulmonary Fibrosis.

	Dr John Mackintosh - Clinician and PhD Student Dr John Mackintosh (BSc, MBBS(Hons), FRACP) is a Respiratory and Lung Transplant Physician at The Prince Charles Hospital, Brisbane. In 2018, John completed a clinical fellowship in interstitial lung disease at the prestigious Royal Brompton Hospital, London. John has developed a keen interest in familial pulmonary fibrosis and the genetics of interstitial lung disease. He is a strong advocate for patients with interstitial lung disease and is passionate about the multi-disciplinary approach to these patients. He is part of a collaboration who were awarded funding through the Medical Research Future Fund to conduct a clinical trial of danazol in people with pulmonary fibrosis related to telomere shortening. He is principal investigator of multiple phase 2 and 3 IPF and PF-ILD clinical trials at The Prince Charles Hospital.

	Dr Stefan Stanel Stefan is an Interstitial Lung Diseases (ILD) consultant currently based in the UK. He trained in Respiratory Medicine in Iasi, Romania, before moving to Manchester as a clinical fellow in ILD. He began his research career in 2020, initially gaining experience as a research physician in early phase Respiratory studies, then started working towards an MD (research) degree with the University of Manchester, focusing on post COVID-19 pulmonary fibrosis and the role of circadian disruption in idiopathic pulmonary fibrosis. He has a special interest in familial ILD and is working towards establishing dedicated familial clinics, registries and multidisciplinary meetings. He is keen to develop an active international research and educational collaboration for projects tackling unmet need in the emerging field of familial and rare ILDs.